Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
50%
Ph phase_4
1
17%
Ph phase_3
1
17%
Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(2)
Other(4)

Detailed Status

unknown4
Completed2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (50.0%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

completed233%
unknown467%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_4

Synbiotics Interventions for Managing Cirrhosis and Its Complications

NCT05687409
unknownphase_2

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

NCT04568265
unknownphase_3

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

NCT04392700
unknownnot_applicable

A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers

NCT03568578
completedphase_2

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

NCT01026610
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05687409Phase 4

Synbiotics Interventions for Managing Cirrhosis and Its Complications

Completed
NCT04568265Phase 2

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

Unknown
NCT04392700Phase 3

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Unknown
NCT03568578Not Applicable

A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers

Unknown
NCT01026610Phase 2

Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Completed
NCT01242787Phase 2

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6